ImmunoGen
IMGN
#2203
Rank
C$12.38 B
Marketcap
C$44.32
Share price
0.00%
Change (1 day)
142.83%
Change (1 year)

ImmunoGen (IMGN) - Total debt

Total debt on the balance sheet as of September 2023 : C$0.11 Billion

According to ImmunoGen 's latest financial reports the company's total debt is C$0.11 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

ImmunoGen - Total debt on balance sheet (from 1996 to 2023)

Total debt by year

Year Total debt Change
2022-12-31C$20.68 M-13.58%
2021-12-31C$23.93 M-21.42%
2020-12-31C$30.46 M-13.13%
2019-12-31C$35.06 M1147.12%
2018-12-31C$2.81 M9.09%
2017-12-31C$2.57 M
2016-06-30C$0.12 B
2001-06-30C$0.01 M-97.89%
2000-06-30C$0.58 M97.96%
1999-06-30C$0.29 M100.12%
1998-06-30C$0.14 M-46.72%
1997-06-30C$0.27 M-94.81%
1996-06-30C$5.31 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
C$78.03 B 65,104.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$66.69 B 55,631.06%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$90.43 B 75,472.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$61.54 B 51,328.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$81.34 B 67,874.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$32.88 B 27,378.60%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
C$65.88 B 54,955.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
C$0.16 B 34.57%๐Ÿ‡บ๐Ÿ‡ธ USA